---
layout: default
title: "Geongyu Lee"
---

<!-- Navigation -->
<div style="width:100%;padding:12px 22px;display:flex;justify-content:flex-end;gap:18px;font-weight:600;">
  <a href="/" style="color:#0366d6;">EN</a>
  <a href="/ko/" style="color:#666;">KR</a>
  <a href="/ja/" style="color:#666;">JP</a>
  <a href="/cn/" style="color:#666;">CN</a>
</div>

# Geongyu Lee
AI Researcher · Computational Pathology · Multi-Omics Modeling

## Professional Summary
AI researcher specializing in **computational pathology** and **multi-omics modeling**, integrating histopathology with proteomic profiles using deep learning. Experienced in foundation model development, cell perturbation prediction, and translational bioinformatics.

Focused on designing **clinically translatable, interpretable biomedical AI models** to support oncology, proteomics-driven precision medicine, and drug discovery workflows.

## Professional Experience
### RadiSen Co., Ltd. (Acquired by OMIXAI) — AI Researcher  
**Feb 2025 – Present**
- Led multi-omics foundation model initiatives integrating proteomics and histopathology for drug response prediction.
- Built self-supervised proteomics representation learning pipelines and LoRA-based fine-tuning mechanisms.
- Co-led Virtual Cell Challenge collaboration predicting pluripotent stem-cell CRISPR knockdown outcomes.
- Advised translational oncology teams on TNBC digital pathology deployment and clinical workflow integration.

### Deep Bio Inc. — AI Researcher  
**Mar 2021 – Jan 2025**
- Built scalable WSI pipelines for early-stage breast cancer recurrence risk prediction.
- Led prostate metastasis detection using cross-modal (H&E + clinical variables) deep learning.
- Developed ADME/Tox prediction frameworks integrating morphological and molecular descriptors.
- Contributed to KFDA regulatory submissions for digital pathology AI validation.

## Education
### Seoul National University of Science and Technology (SeoulTech)
**M.S. in Data Science (2019–2021)**  
- Advisor: *Prof. Sangheum Hwang*  
- Thesis: **Utilizing Contrastive Loss to Improve Segmentation Model Performance**

### Daejeon University  
**B.S. in Information Security (2012–2019)**

## Selected Publications
- Assessing the risk of recurrence in early-stage breast cancer through H&E-stained whole slide images. *Scientific Reports*, 2025.
- AI-driven Digital Pathology in Urological Cancers. *Pattern Recognition in Life Sciences / Prostate International*, 2025.
- MurSS: Multi-Resolution Selective Segmentation Model for Breast Cancer. *Bioengineering*, 2024.
- Supervised Contrastive Embedding for Medical Image Segmentation. *IEEE Access*, 2022.

## Preprints & Abstracts
- G2L: From Giga-Scale to Cancer-Specific Pathology Foundation Models via Knowledge Distillation. *arXiv*, 2025.
- KPI Challenge 2024: Glomerular Segmentation. *arXiv*, 2025.
- Predicting Protein Receptor Status from H&E-Stained Images. *AACR*, 2023.
- Automatic Histological Grading of Breast Cancer Resection Tissue. *USCAP*, 2022.

## Honors & Awards
- **2nd Place — Glomeruli Segmentation (WSI Level)**, KPI Challenge 2024  
- **7th Place — Apartment Price Prediction**, Dacon × Zigbang (2018)

## Technical Skills
### Languages
Python, R, JavaScript, Bash

### Frameworks  
PyTorch, FastAPI, scikit-learn, Transformers

### Tools  
Docker, Git, Linux, VS Code

### Domains  
Deep Learning, Computational Pathology, Multi-Omics Integration, Protein Modeling

## Research Interests
Computational Pathology · Multi-Omics Integration · Proteomics Modeling  
Biomedical Foundation Models · Interpretability · Cell Perturbation Prediction
